Safety and Immunogenicity of LNP-nCOV saRNA-02 Vaccine Against SARS-CoV-2, the Causative Agent of COVID-19
Clinical trial NCT04934111 · UNKNOWN
Trial details
- NCT number
- NCT04934111
- Sponsor
- MRC/UVRI and LSHTM Uganda Research Unit
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-02
- Primary completion
- 2022-11-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.